Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: study design and methodology for a cluster randomized controlled trial

This manuscript describes the study design and methodology of a cluster-randomized controlled trial to evaluate a mass testing and treatment approach for malaria transmission reduction in an area of high malaria transmission in western Kenya.

Author: , , , , , , , , , , , , , , , , , ,
Publication date: June 2017
Source: Malaria Journal

Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial

RTS, S/AS01 was well tolerated when given to children with WHO clinical stage 1 or 2 HIV disease along with high antiretroviral and co-trimoxazole use. Children with HIV disease could be included in future RTS,S/AS01 vaccination programmes.

Author: , , , , , , , , , , , , , , , , , , , , , , , , , ,
Publication date: October 2016
Source: The Lancet Infectious Diseases